A rapid approach to generate immortalised B cells for monoclonal antibody generation from SARS-CoV-2 recovered and vaccinated group
Implementing Organization
Rajiv Gandhi Centre for Biotechnology (RGCB)
Visit
Principal Investigator
Dr TR Santhosh Kumar
Scientist, Rajiv Gandhi Centre for Biotechnology (RGCB), Kerala
Project Overview
This study aims to identify subset of COVID-19 recovered patients and immunised volunteers with high titer neutralising antibodies for the in vitro B cell immortalisation for neutralising antibody generation.